bunazosin has been researched along with Bladder Disorder, Neurogenic in 6 studies
bunazosin: structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bunazosin hydrochloride was orally administered 1." | 2.67 | [Clinical evaluation of bunazosin hydrochloride for the treatment of voiding disturbances due to neurogenic bladder--a double-blind study]. ( Aso, Y; Honma, Y; Koyanagi, T; Maru, A; Miyake, K; Orikasa, S; Shimazaki, J; Soma, F; Togashi, M; Yasuda, K, 1990) |
| " A dosage of 12 mg/day did not improve subjective symptoms more than did the 9 mg/day dose." | 2.66 | [Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction]. ( Kondo, A; Mitsuya, H; Otani, T; Takita, T, 1987) |
| " Stomatitis was observed in only one case as a side effect of this drug." | 1.28 | [Usefulness and safety of bunazosin hydrochloride in neurogenic bladder after prolonged administration]. ( Gotoh, S; Hiraga, S; Hosoda, K; Kakehi, R; Kaneoya, F; Kojima, S; Mizuo, T; Satoh, T; Tanizawa, A; Yokokawa, M, 1992) |
| "The rate of effectiveness for neurogenic bladders was as high as 80% whereas that for lower urethral obstruction was much lower: 57%." | 1.27 | [Clinical effect of new alpha-adrenergic blocker on micturition disturbance of neurogenic bladder and lower urinary tract obstruction]. ( Amagai, T; Fuse, T; Hirano, D; Kawazoe, K; Kitamura, K; Kiyotaki, S; Takimoto, Y, 1983) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takimoto, Y | 1 |
| Kitamura, K | 1 |
| Fuse, T | 1 |
| Kawazoe, K | 1 |
| Hirano, D | 1 |
| Amagai, T | 1 |
| Kiyotaki, S | 1 |
| Hiraga, S | 1 |
| Satoh, T | 1 |
| Kakehi, R | 1 |
| Kojima, S | 1 |
| Yokokawa, M | 1 |
| Gotoh, S | 1 |
| Kaneoya, F | 1 |
| Mizuo, T | 1 |
| Tanizawa, A | 1 |
| Hosoda, K | 1 |
| Koyanagi, T | 1 |
| Togashi, M | 1 |
| Maru, A | 1 |
| Orikasa, S | 1 |
| Soma, F | 1 |
| Shimazaki, J | 1 |
| Yasuda, K | 1 |
| Aso, Y | 1 |
| Honma, Y | 1 |
| Miyake, K | 1 |
| Araki, T | 1 |
| Nakano, S | 1 |
| Sugimura, Y | 1 |
| Tochigi, H | 1 |
| Kawamura, J | 1 |
| Kato, T | 1 |
| Tajima, K | 1 |
| Chigusa, I | 1 |
| Saito, K | 1 |
| Morisita, H | 1 |
| Takita, T | 1 |
| Kondo, A | 1 |
| Mitsuya, H | 1 |
| Otani, T | 1 |
| Murayama, K | 1 |
| Katsumi, T | 1 |
| Nakamura, T | 1 |
| Tazika, E | 1 |
| Sakai, A | 1 |
| Haginaka, T | 1 |
3 trials available for bunazosin and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
[Clinical evaluation of bunazosin hydrochloride for the treatment of voiding disturbances due to neurogenic bladder--a double-blind study].
Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Bethanechol; Bethanechol Compounds; Chi-Squar | 1990 |
[Clinical study of bunazosin hydrochloride, an alpha 1-adrenergic blocker, in benign prostatic obstruction and neurogenic bladder dysfunction].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Clinical Trials as Topic; | 1987 |
[A double blind clinical trial of the alpha-adrenergic blocker, Ea-0643 tablet, in the treatment of neurogenic bladder].
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Clinical Trials as Topic; Double-Blind Method | 1985 |
3 other studies available for bunazosin and Bladder Disorder, Neurogenic
| Article | Year |
|---|---|
[Clinical effect of new alpha-adrenergic blocker on micturition disturbance of neurogenic bladder and lower urinary tract obstruction].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Female; Humans; Male; Middle Aged; Quinazolines; Urethral | 1983 |
[Usefulness and safety of bunazosin hydrochloride in neurogenic bladder after prolonged administration].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Drug Evaluation; Female; Humans; Male; Middle Aged; Quina | 1992 |
[Efficacy of combination of Ea-0643 (bunazosin hydrochloride) and bethanechol chloride in patients with neurogenic bladder].
Topics: Adrenergic alpha-Antagonists; Aged; Bethanechol; Bethanechol Compounds; Drug Evaluation; Drug Therap | 1990 |